Sign in

CIK 0001638287

  • Non-accelerated filer
  • Smaller reporting company

MetaVia Inc.

Sign in to watch
Ticker
MTVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472389984
Phone
+1 857-702-9600
Business address
545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA, 02138
Former names
NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 19 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-11-03 Price Ben Gil CEO and President Grant or award · Nonstatutory Stock Option (right to buy) +616,666 616,666
2021-09-02 KOVEN ANDREW I Director Grant or award · Nonstatutory Stock Option (right to buy) +60,000 60,000
2020-12-31 Bakshi Akash SVP and COO Grant or award +29,013 29,013
2020-12-31 Bakshi Akash SVP and COO Grant or award +855,059 884,072
2020-09-01 Swirsky Douglas J Director Grant or award · Non-qualified stock option (right to buy) +60,000 60,000
2020-01-13 Salsbury Michael Director Grant or award · Non-qualified stock option (right to buy) +60,000 60,000
2020-01-13 Oh Jeong Gyun Director Grant or award · Non-qualified stock option (right to buy) +60,000 60,000
2020-01-13 Kim Na Yeon Director Grant or award · Non-qualified stock option (right to buy) +60,000 60,000
2020-01-13 Jeong Tae Heum Director Grant or award · Non-qualified stock option (right to buy) +60,000 60,000
2020-01-13 Gullans Steven R. Ph.D. Director Grant or award · Non-qualified stock option (right to buy) +60,000 60,000
2020-01-13 GROVES JASON L Director Grant or award · Non-qualified stock option (right to buy) +60,000 60,000
2019-12-30 Versavel Mark Chief Medical Officer Grant or award · Stock Option (right to buy) +297,206 297,206
2019-12-30 Versavel Mark Chief Medical Officer Grant or award · Stock Option (right to buy) +45,724 45,724
2019-12-30 Oh Jeong Gyun Director Grant or award +1,817,842 1,817,842
2019-12-30 Oh Jeong Gyun Director Grant or award +240,051 240,051
2019-12-30 Kim Na Yeon Director Grant or award +4,335,800 4,335,800
2019-12-30 Kim Na Yeon Director Grant or award +1,121,190 1,121,190
2019-12-30 Kim Na Yeon Director Grant or award +1,864,799 1,864,799
2019-07-24 SASSINE ANDY Director Grant or award +15,000 151,264
2019-07-24 LICHTINGER PEDRO Director Grant or award +15,000 74,833

Page 4 of 7 · 135 trades